Juul and Its Courtroom Foes Stare Down FDA Ban as Trial Nears

June 28, 2022, 2:00 PM UTC

The Food and Drug Administration’s orderto Juul Labs Inc. to take its products off shelves in the US threatens to undermine the e-cigarette maker’s defense in a sprawling legal fight over its youth marketing practices.

But it also raises the risk of scant payoffs for those suing, if Juul ultimately loses its appeal over the ban.

While a federal court on Friday gave Juul some respite by temporarily blocking the FDA order, both sides now have extra incentive to settle more than 2,500 personal injury lawsuits and hundreds more cases brought by local governments and school districts seeking to ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.